Annual SGA
$111.53 M
-$5.29 M-4.53%
December 31, 2024
Summary
- As of March 10, 2025, BEAM annual SGA is $111.53 million, with the most recent change of -$5.29 million (-4.53%) on December 31, 2024.
- During the last 3 years, BEAM annual SGA has risen by +$54.30 million (+94.90%).
- BEAM annual SGA is now -4.53% below its all-time high of $116.81 million, reached on December 31, 2023.
Performance
BEAM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$28.66 M
+$2.15 M+8.09%
December 31, 2024
Summary
- As of March 10, 2025, BEAM quarterly SGA is $28.66 million, with the most recent change of +$2.15 million (+8.09%) on December 31, 2024.
- Over the past year, BEAM quarterly SGA has stayed the same.
- BEAM quarterly SGA is now -33.74% below its all-time high of $43.26 million, reached on December 31, 2023.
Performance
BEAM Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$5.71 B
-$376.74 M-7.06%
December 31, 2024
Summary
- As of March 10, 2025, BEAM TTM SGA is -$5.71 billion, with the most recent change of -$376.74 million (-7.06%) on December 31, 2024.
- Over the past year, BEAM TTM SGA has dropped by -$5.82 billion (-5220.89%).
- BEAM TTM SGA is now -4479.19% below its all-time high of -$124.72 million.
Performance
BEAM TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BEAM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | 0.0% | -5220.9% |
| 3 y3 years | +94.9% | 0.0% | -5220.9% |
| 5 y5 years | +442.6% | 0.0% | -5220.9% |
BEAM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | +94.9% | -33.7% | +61.3% | -107.9% | at low |
| 5 y | 5-year | -4.5% | +442.6% | -33.7% | +365.3% | -968.6% | at low |
| alltime | all time | -4.5% | +839.7% | -33.7% | +911.3% | -4479.2% | at low |
Beam Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $111.53 M(-4.5%) | $28.66 M(+8.1%) | $111.53 M(-11.6%) |
| Sep 2024 | - | $26.52 M(-10.5%) | $126.12 M(+0.9%) |
| Jun 2024 | - | $29.63 M(+10.9%) | $125.02 M(+4.1%) |
| Mar 2024 | - | $26.72 M(-38.2%) | $120.05 M(+2.8%) |
| Dec 2023 | $116.81 M(+33.0%) | $43.26 M(+70.2%) | $116.81 M(+21.4%) |
| Sep 2023 | - | $25.41 M(+3.1%) | $96.24 M(+3.9%) |
| Jun 2023 | - | $24.66 M(+5.0%) | $92.64 M(+0.6%) |
| Mar 2023 | - | $23.49 M(+3.6%) | $92.05 M(+4.8%) |
| Dec 2022 | $87.81 M(+53.4%) | $22.68 M(+4.0%) | $87.81 M(+5.9%) |
| Sep 2022 | - | $21.82 M(-9.3%) | $82.90 M(+7.9%) |
| Jun 2022 | - | $24.06 M(+25.0%) | $76.86 M(+16.1%) |
| Mar 2022 | - | $19.25 M(+8.3%) | $66.20 M(+15.7%) |
| Dec 2021 | $57.22 M | $17.77 M(+12.7%) | $57.22 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $15.77 M(+17.7%) | $47.80 M(+20.9%) |
| Jun 2021 | - | $13.40 M(+30.5%) | $39.53 M(+19.6%) |
| Mar 2021 | - | $10.27 M(+23.0%) | $33.07 M(+11.7%) |
| Dec 2020 | $29.61 M(+44.0%) | $8.35 M(+11.4%) | $29.61 M(+8.0%) |
| Sep 2020 | - | $7.50 M(+8.1%) | $27.41 M(+7.9%) |
| Jun 2020 | - | $6.94 M(+1.8%) | $25.40 M(+8.4%) |
| Mar 2020 | - | $6.81 M(+10.6%) | $23.44 M(+14.0%) |
| Dec 2019 | $20.55 M(+73.2%) | $6.16 M(+12.3%) | $20.55 M(+13.5%) |
| Sep 2019 | - | $5.49 M(+10.2%) | $18.10 M(+17.2%) |
| Jun 2019 | - | $4.98 M(+26.7%) | $15.45 M(+47.5%) |
| Mar 2019 | - | $3.93 M(+5.9%) | $10.47 M(+60.0%) |
| Dec 2018 | $11.87 M | $3.71 M(+30.9%) | $6.54 M(+130.9%) |
| Sep 2018 | - | $2.83 M | $2.83 M |
FAQ
- What is Beam Therapeutics annual SGA?
- What is the all time high annual SGA for Beam Therapeutics?
- What is Beam Therapeutics annual SGA year-on-year change?
- What is Beam Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Beam Therapeutics?
- What is Beam Therapeutics quarterly SGA year-on-year change?
- What is Beam Therapeutics TTM SGA?
- What is the all time high TTM SGA for Beam Therapeutics?
- What is Beam Therapeutics TTM SGA year-on-year change?
What is Beam Therapeutics annual SGA?
The current annual SGA of BEAM is $111.53 M
What is the all time high annual SGA for Beam Therapeutics?
Beam Therapeutics all-time high annual SGA is $116.81 M
What is Beam Therapeutics annual SGA year-on-year change?
Over the past year, BEAM annual SGA has changed by -$5.29 M (-4.53%)
What is Beam Therapeutics quarterly SGA?
The current quarterly SGA of BEAM is $28.66 M
What is the all time high quarterly SGA for Beam Therapeutics?
Beam Therapeutics all-time high quarterly SGA is $43.26 M
What is Beam Therapeutics quarterly SGA year-on-year change?
Over the past year, BEAM quarterly SGA has changed by $0.00 (0.00%)
What is Beam Therapeutics TTM SGA?
The current TTM SGA of BEAM is -$5.71 B
What is the all time high TTM SGA for Beam Therapeutics?
Beam Therapeutics all-time high TTM SGA is -$124.72 M
What is Beam Therapeutics TTM SGA year-on-year change?
Over the past year, BEAM TTM SGA has changed by -$5.82 B (-5220.89%)